Theophanous S, Lønne PI, Choudhury A, Berbee M, Deijen C, Dekker A, Field M, Gambacorta MA, Gilbert A, Grønlie Guren M, Jadon R, Kochhar R, Martin D, Mohamed AA, Muirhead R, Parés O, Raszewski Ł, Roy R, Scarsbrook A, Sebag-Montefiore D, Spezi E, Vassiliou V, Malinen E, Wee L, Appelt A et al. (2026)
An international multi-centre study to develop and validate federated learning-based prognostic models for anal cancer
Nat Commun (in press)
DOI 10.1038/s41467-026-70297-3, PubMed 41832163

Brandal SHB, Mo T, Fangberget A, Nilsen LB, Geier OM, Bjørndal H, Holmen MM, Engebråten O, Garred Ø, Hole KH, Seierstad T (2026)
MRI for Predicting Response and 10-Year Outcome of Neoadjuvant Chemotherapy with or Without Additional Bevacizumab Treatment in HER2-Negative Breast Cancer
Cancers (Basel), 18 (3)
DOI 10.3390/cancers18030393, PubMed 41681863

Fracchiolla F, Meijers A, Orlandi E, Korevaar E, Whitfield G, Jensen K, Hoogeman M, Wijsman R, Jouglar E, Weerd EV, Pérez JM, Rinaldi I, Garbacz-Stryszewska M, Cianchetti M, Feijoo MM, Molinelli S, Elstrøm UV, Pica A, Gosling A, Koczur B, Dahlgren CV, Alterio D, Dale E, Farid G, Compter I et al. (2025)
An ESTRO-EPTN Delphi consensus on robustness evaluation in proton therapy
Phys Imaging Radiat Oncol, 37, 100900
DOI 10.1016/j.phro.2025.100900, PubMed 41550258